On the notable occasion of World Cancer Day 2025, let’s celebrate Bollywood celebrities who bravely fought and triumphed over ...

Essendon VFL senior coach Dale Tapping has tragically died on Tuesday aged 59 after being diagnosed with myeloma, an aggressive form of blood cancer, in 2023.

The AFL is grieving the loss of Essendon coach Dale Tapping, who passed away on Tuesday morning at the age of 59 after a ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

A Coromandel police officer who narrowly escaped death on the front line has been diagnosed with blood cancer and is now ...

The panelist discusses how for managing patients with R/R multiple myeloma, community clinicians should focus on personalized ...

Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, ...

Ashraf Z. Badros, MB, ChB, discusses the next steps following the phase 3 AURIGA trial of daratumumab and lenalidomide vs lenalidomide maintenance in patients with newly diagnosed multiple myeloma.

Study reveals VLCFA metabolism as a key target in multiple myeloma, enhancing drug efficacy and overcoming resistance.

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...